Abstract: This invention is directed to a mattress assembly for use in a sofa sleeper. The mattress assembly has an outer shell and an inner support received within the outer shell. The shell includes a lower panel, a sidewall, and a cover that fit together to form a cavity to receive the inner support. The inner support includes an air bladder and an innerspring portion. The air bladder has a valve that is adapted to allow air into and out of the bladder. The air bladder is deflated when the mattress is stored to provide a compact configuration.

Abstract: This invention is directed to a mattress assembly for use in a sofa sleeper. The mattress assembly has an outer shell and an inner support received within the outer shell. The shell includes a lower panel, a sidewall, and a cover that fit together to form a cavity to receive the inner support. The inner support includes an air bladder and an innerspring portion. The air bladder has a valve that is adapted to allow air into and out of the bladder. The air bladder is deflated when the mattress is stored to provide a compact configuration.

Abstract: Inhibitors of wax deposition for crude oils are polymers of a monomer with structural units derived from at least one ester (i) of an aliphatic carboxylic acid with an aliphatic alcohol, wherein one of the acid and alcohol is ethylenically unsaturated and the other of the acid and alcohol has a long chain group of 14-40 carbons, and a monomer with structural units derived from a corresponding ester (3) with structural units derived from an aliphatic carboxylic acid and an aliphatic alcohol, wherein one of the acid and alcohol is ethylenically unsaturated and the other has an aliphatic group of 1-13 carbons, such that at least 30% preferably 50-90% of the said aliphatic groups have 15-35 carbons. They are preferably made by transesterification. Blends of such polymers and/or the corresponding homopolymers or copolymers of ester 1 and/or polyalkylene imines with long side chains, and optionally with monomeric polar additives may be used as inhibitors.

Abstract: A hydrate inhibitor comprising a blend of an additive (i) and at least one of an additive (ii) and an additive (iii) wherein additive (i) is a polymer of an ethylenically unsaturated N-heterocyclic carbonyl compound, with 6-8 ring atoms in the heterocyclic ring, additive (ii) is a corrosion inhibitor and additive (iii) is a salt of formula (I):[R1(R2)XR3]+Y− 1/v, I wherein each of R1, R2 and R3 is bonded directly to X, each of R1 and R2, which may be the same or different is an alkyl group of at least 4 carbons, X is S, NR4 or PR4, wherein each of R3 and R4 which may be the same or different represents hydrogen or an organic group, with the proviso that at least one of R3 and R4 is an organic group of at least 4 carbons, especially at least 5 carbons, and Y is an anion of valency v, wherein v is an integer of 1-4.

Abstract: A method of reducing the deposition of wax from a crude oil containing wax which comprises adding thereto at least one N-substituted polyalkylene imine which has at least one organic substituent that is a hydroxy-substituted alkyl group of 12-24 carbon atoms.

Abstract: Compounds of formula (I) are diuretic agents for treating various cardiovascular diseases including hypertension, heart failure and renal insufficiency.

Abstract: The invention provides the substantially optically pure 2(S)-stereoisomeric form of compounds of the formulae: ##STR1## and the salts thereof, together with processes for their preparation. The compounds are intermediates for the preparation of antihypertensive agents.

Abstract: A series of novel spiro-substituted glutaramide derivatives have been prepared, including the pharmaceutically acceptable salts thereof and bioprecursors therefor, wherein the spiro-substituent completes a 5- or 6- membered carbocyclic ring and is located at the carbon atom adjacent to the carbamoyl group. These particular compounds are inhibitors of the neutral endopeptidase E.C.3,4.24.11 enzyme and are therefore useful in therapy as diuretic agents for the treatment of hypertension, heart failure, renal insufficiency and other disorders. Methods for preparing these compounds from known starting materials are provided.

Abstract: The invention provides the substantially optically pure 2(S)-steroisomeric form of compounds of the formulae: ##STR1## and the salts thereof, together with processes for their preparation. The compounds are intermediates for the preparation of antihypertensive agents.

Abstract: The invention provides the substantially optically pure 2(S)-stereoisomeric form of compounds of the formulae: ##STR1## and the salts thereof, together with processes for their preparation. The compounds are intermediates for the preparation of antihypertensive agents.

Abstract: 2-Acylaminoalkyl-3-[1-(carboxycycloalkylcarbamoyl)cycloalkyl]propanoic acid derivatives (which may also be viewed as glutaramide derivatives) are useful in the treatment of hypertension, heart failure and renal insufficiency, based upon their inhibition of zinc-dependent, neutral endopiptidase.

Abstract: A series of novel spiro-substituted glutaramide derivatives have been prepared, including the pharmaceutically acceptable salts thereof and bioprecursors therefor, wherein the spiro-substituent completes a 5- or 6-membered carbocycyclic ring and is located at the carbon atom adjacent to the carbamoyl group. These particular compounds are inhibitors of the neutral endopeptidase E.C.3.4.24.11 enzyme and are therefore useful in therapy as diuretic agents for the treatment of hypertension, heart failure, renal insufficiency and other disorders. Methods for preparing these compounds from known starting materials are provided.

Abstract: Compounds of the formula ##STR1## wherein A is a carbocyclic, saturated or unsaturated ring; R.sup.1 is hydrogen or alkyl; R and R.sup.4 are each alkyl, cycloalkyl, benzyl or a readily hydrolyzable ester group; Y is a bond or a straight or branch alkylene; R.sup.2 is hydrogen, aryl, heterocyclic, R.sup.6 CONR.sup.5, R.sup.7 NR.sup.5 CO, R.sup.7 NR.sup.5 SO.sub.2 --or R.sup.8 SO.sub.2 NR.sup.5 --where R.sup.5 is hydrogen, alkyl or aralkyl; R.sup.6 is alkyl, aryl, aralkyl, heterocyclic, heterocyclyalkyl or a group of the formula ##STR2## where R.sup.9 is hydrogen, hydroxy, alkoxy, alkyl, hydroxyalkyl, aralkyl, alkylene, heterocyclic, heterocyclylalkyl, R.sup.12 CONH--, R.sup.12 SO.sub.2 NH-- or (R.sup.13).sub.2 N--; R.sup.10 and R.sup.11 are each hydrogen or alkyl; or R.sup.10 is hydrogen and R.sup.11 is aminoalkyl, imidazolylmethyl, aryl, aralkyl, aralkoxyalkoxy, hydroxyalkyl or methylthioalkyl; or R.sup.10 and R.sup.

Abstract: 2-Acylaminoalkyl-3-[1-(carboxycycloalkylcarbamoyl)cycloalkyl]propanoic acid derivatives (which may also be viewed as glutaramide derivatives) are useful in the treatment of hypertension, heart failure and renal insufficiency, based upon their inhibition of zinc-dependant, neutral endopiptidase.

Abstract: Organic material, particularly organic material floating on a water surface, can be encapsulated by reacting, in the presence of the organic material, (A) a functionalized liquid polymer containing anhydride functional groups which groups are derived from an alpha, beta-ethylenically unsaturated dicarboxylic acid anhydride and (B) an alkoxylated fatty monoamine or polyamine having from 1.5 to 15 moles of alkoxylate per mole of fatty amine. The functionalized polymer (A) may be, for example, maleinized polybutadiene and the alkoxylated fatty amine may be, for example, N,N.sup.1, N.sup.1 -tris (2-hydroxypropyl)-N-oleyl-1,3-diaminopropane. Preferably, the alkoxylated fatty amine is derived from a fatty amine having an iodine value of at least 65. The method may also be used to encapsulate a solid contaminated with organic material e.g. oil drilling cuttings.

Abstract: A two part impression material suitable for use as a dental impression material comprises a first part containing a product of the reaction of an alpha, beta-ethylenically unsaturated dicarboxylic acid anhydride, such as maleic anhydride, and a liquid polydiene resin, e.g. polybutadiene, and a second part containing a setting agent for the reaction product which setting agent is an alkoxylated fatty mono-amine or an alkoxylated fatty polyamine having from 2 to 30, preferably 5 to 15 moles of alkoxylate per mole of the fatty amine. The alkoxylate groups of the setting agent being one or more groups selected from the group comprising ethoxylate, propoxylate and butoxylate groups. A method of taking a dental impression using the reaction product of the first and second parts of the two part dental impression material is also disclosed.